Advanced Search


Study ID Status Title Patient Level Data
114993 Completed SUrvey of Guideline Adherence for treatment of systolic heart failure in Real WorldMulticenter, retrospective observation study in Korea
115002 Active not recruiting PGx308, PGx309, PGx310 and PGx382 evaluation of efficacy and safety endpoints in pazopanib-treated renal cell carcinoma (RCC) patients in studies VEG102616, VEG105192, and VEG107769
115003 Completed PGx367 evaluation of ALT elevation in patients receiving pazopanib and statins in 11 pazopanib clinical studies (VEG102616, VEG105192, VEG107769, VEG10003, VEG10004, VEG10005, VEG10007, VEG20002, VEG20006, VEG104450, VEG105281)
115008 Completed Medical Record Review and Data Abstraction for Pediatric, Adolescent and Pregnant Patients treated with IV zanamivir in the Relenza Compassionate Use Program Study Listed on
115014 Completed SLE in CEE setting( Hungary, Poland, Romania) an insight on medical, economic and social burden
115030 Completed Efficacy and Safety of Belimumab in a Subgroup of Systemic Lupus Erythematosus (SLE) Patients with Higher Disease Activity (anti-dsDNA positive and low complement): A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
115032 Completed A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
115040 Terminated A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects Study Listed on
115049 Completed Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
115054 Completed Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. Study Listed on
115055 Recruiting A cohort event monitoring study to define the incidence of diseases specified as protocol-defined potential adverse events of specific interest (AESI) and serious adverse events (SAE) in infants and children in Africa prior to implementation of the RTS,S/AS01E candidate vaccine.
115058 Completed Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects from primary care
115060 Completed A meta-analysis of three studies to evaluate key efficacy outcomes in subjects with moderate-to-severe Restless Legs Syndrome treated with Gabapentin Enacarbil at doses ranging from 600 mg/day to 2400 mg/day
115064 Completed Determination of the Absolute Bioavailability of GSK1120212 Following a Single Oral Dose Co-Administered with an Intravenous Radiolabelled Microdose of GSK1120212 in Subjects with solid Tumors
115066 Completed Drug Use Investigation for XYZAL
115067 Completed A Meta Analysis to compare the efficacy of Acyclovir 3% ophthalmic ointment to Idoxuridine in curing herpes keratitis after 7-days of treatment
115068 Active not recruiting Special Drug Use Investigation for XYZAL (Long-term)
115070 Completed Phase1 study of GR121167- A double blind, placebo controlled, randomized, dose ascending, single and multiple dose study to investigate the safety and pharmacokinetics following intravenous administration of GR121167 in healthy Japanese males- Study Listed on
115083 Completed A Phase I Study to Evaluate a Single Oral Dose of SRT2379 on the Endotoxin Induced Inflammatory Response in Healthy Male Subjects Study Listed on
115096 Completed A Randomized, Open-label, Single-Dose, Two-Period, Crossover Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers Study Listed on
115102 Completed A double-blind, randomized, placebo controlled, multicenter, dose-finding trial of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) patients
115114 Completed Validation of the new COPD Assessment Test translated into Korean in patients with Chronic Obstructive Pulmonary Disease
115115 Completed Safety and immunogenicity study of a prime-boost schedule of GSK Biologicals' influenza vaccine GSK1562902A in children aged 3 to 17 years Study Listed on
115117 Completed A single-centre. double-blind, placebo controlled three part study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and repeat doses of nebulised GSK2269557 in healthy male subjects Study Listed on
115119 Completed A Double-Blind (sponsor unblind), Placebo Controlled, Randomised, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of GSK2269557 Administered as a Dry Powder to COPD Patients and Assessment of Dose Response using Sputum Biomarkers



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.